BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 26350517)

  • 1. Patients with hidradenitis suppurativa carry a higher systemic inflammatory load than other dermatological patients.
    Riis PT; Søeby K; Saunte DM; Jemec GB
    Arch Dermatol Res; 2015 Dec; 307(10):885-9. PubMed ID: 26350517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS).
    Hessam S; Sand M; Gambichler T; Bechara FG
    J Am Acad Dermatol; 2015 Dec; 73(6):998-1005. PubMed ID: 26410359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocyte Profile in Peripheral Blood and Neutrophil-Lymphocyte Ratio in Hidradenitis Suppurativa: A Comparative Cross-Sectional Study of 462 Cases.
    Miller IM; Ring HC; Prens EP; Rytgaard H; Mogensen UB; Ellervik C; Jemec GB
    Dermatology; 2016; 232(4):511-9. PubMed ID: 27287331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil to lymphocyte ratio as a measure of systemic inflammation in psoriasis.
    Sen BB; Rifaioglu EN; Ekiz O; Inan MU; Sen T; Sen N
    Cutan Ocul Toxicol; 2014 Sep; 33(3):223-7. PubMed ID: 24147939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis.
    Scheinfeld N
    Dermatol Online J; 2013 Jun; 19(6):18558. PubMed ID: 24011308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of adalimumab on T-helper-17 lymphocyte- and neutrophil-related inflammatory serum markers in patients with moderate-to-severe hidradenitis suppurativa.
    Jiménez-Gallo D; de la Varga-Martínez R; Ossorio-García L; Collantes-Rodríguez C; Rodríguez C; Linares-Barrios M
    Cytokine; 2018 Mar; 103():20-24. PubMed ID: 29289722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum amyloid A and C-reactive protein levels and erythrocyte sedimentation rate are important indicators in hidradenitis suppurativa.
    Akdogan N; Dogan S; Incel-Uysal P; Karabulut E; Topcuoglu C; Yalcin B; Atakan N
    Arch Dermatol Res; 2020 May; 312(4):255-262. PubMed ID: 31729595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High inflammation in hidradenitis suppurativa extends to perilesional skin and can be subdivided by lipocalin-2 expression.
    Navrazhina K; Garcet S; Zheng X; Hur HB; Frew JW; Krueger JG
    J Allergy Clin Immunol; 2022 Jan; 149(1):135-144.e12. PubMed ID: 34081946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of metabolic syndrome and hidradenitis suppurativa.
    Miller IM; Ellervik C; Vinding GR; Zarchi K; Ibler KS; Knudsen KM; Jemec GB
    JAMA Dermatol; 2014 Dec; 150(12):1273-80. PubMed ID: 25229996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An atlas of the morphological manifestations of hidradenitis suppurativa.
    Scheinfeld N
    Dermatol Online J; 2014 Apr; 20(4):22373. PubMed ID: 24746309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the laboratory parameters in hidradenitis suppurativa: Can we use new inflammatory biomarkers?
    Çetinarslan T; Türel Ermertcan A; Özyurt B; Gündüz K
    Dermatol Ther; 2021 Mar; 34(2):e14835. PubMed ID: 33527638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal Skin Microbiota is Altered in Pre-clinical Hidradenitis Suppurativa.
    Ring HC; Bay L; Kallenbach K; Miller IM; Prens E; Saunte DM; Bjarnsholt T; Jemec GB
    Acta Derm Venereol; 2017 Feb; 97(2):208-213. PubMed ID: 27377144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of miRNA-155, miRNA-223, miRNA-31, miRNA-21, miRNA-125b, and miRNA-146a in the Inflammatory Pathway of Hidradenitis Suppurativa.
    Hessam S; Sand M; Skrygan M; Gambichler T; Bechara FG
    Inflammation; 2017 Apr; 40(2):464-472. PubMed ID: 28028756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hidradenitis Suppurativa in Patients With Inflammatory Bowel Disease: A Population-Based Cohort Study in Olmsted County, Minnesota.
    Yadav S; Singh S; Edakkanambeth Varayil J; Harmsen WS; Zinsmeister AR; Tremaine WJ; Davis MD; Wetter DA; Colombel JF; Loftus EV
    Clin Gastroenterol Hepatol; 2016 Jan; 14(1):65-70. PubMed ID: 25952308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the Use of Hematological Parameters in Staging Hidradenitis Suppurativa.
    Yaşar NF; Uylas MU; Baspinar M; Sarsilmaz H; Ates E; Erkasap S; Sahin A
    Wounds; 2016 Nov; 28(11):87-91. PubMed ID: 28054922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression in patients with hidradenitis suppurativa.
    Onderdijk AJ; van der Zee HH; Esmann S; Lophaven S; Dufour DN; Jemec GB; Boer J
    J Eur Acad Dermatol Venereol; 2013 Apr; 27(4):473-8. PubMed ID: 22339940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation induced changes in the expression levels of components of the microRNA maturation machinery Drosha, Dicer, Drosha co-factor DGRC8 and Exportin-5 in inflammatory lesions of hidradenitis suppurativa patients.
    Hessam S; Sand M; Skrygan M; Gambichler T; Bechara FG
    J Dermatol Sci; 2016 Jun; 82(3):166-74. PubMed ID: 26917346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-Depth Analysis of the Hidradenitis Suppurativa Serum Proteome Identifies Distinct Inflammatory Subtypes.
    Navrazhina K; Garcet S; Gonzalez J; Grand D; Frew JW; Krueger JG
    J Invest Dermatol; 2021 Sep; 141(9):2197-2207. PubMed ID: 33766512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete blood collection-based systemic inflammation biomarkers for patients with hidradenitis suppurativa.
    Gambichler T; Hessam S; Cramer P; Abu Rached N; Bechara FG
    J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1593-1596. PubMed ID: 35462426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epicardial fat thickness is ıncreased and associated with disease severity in hidradenitis suppurativa.
    Alatas ET; Biteker M; Alatas OD
    Arch Dermatol Res; 2020 Sep; 312(7):467-472. PubMed ID: 31894390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.